South Korea Clinical Trial Patient Recruitment Services Market Size & Outlook

The clinical trial patient recruitment services market in South Korea is expected to reach a projected revenue of US$ 45.6 million by 2030. A compound annual growth rate of 9.5% is expected of South Korea clinical trial patient recruitment services market from 2024 to 2030.
Revenue, 2023 (US$M)
$24.2
Forecast, 2030 (US$M)
$45.6
CAGR, 2024 - 2030
9.5%
Report Coverage
South Korea

South Korea clinical trial patient recruitment services market, 2018-2030 (US$M)

South

Related Markets

South Korea clinical trial patient recruitment services market highlights

  • The South Korea clinical trial patient recruitment services market generated a revenue of USD 24.2 million in 2023 and is expected to reach USD 45.6 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial patient recruitment services market data book summary

Market revenue in 2023USD 24.2 million
Market revenue in 2030USD 45.6 million
Growth rate9.5% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV
Key market players worldwideThermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.7% of the global clinical trial patient recruitment services market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China clinical trial patient recruitment services market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 29.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Patient Recruitment Services Market Scope

Clinical trial patient recruitment services market segmentation & scope
Phase I
Phase II
Phase III
Phase IV
Patient recruitment & Registry Services
Patient retention
Others
Respiratory Diseases
Pain and Anesthesia
Oncology
Central Nervous System
Cardiovascular
Anti-Infective
Cardiology
CNS
Enodcrine
Pain Mangement
Others
Child (Birth-17 Years)
Adult (18 - 64 Years)
Older Adults (65 Years+)

Clinical Trial Patient Recruitment Services Market Companies

Name Profile # Employees HQ Website

South Korea clinical trial patient recruitment services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 57.44% in 2023. Horizon Databook has segmented the South Korea clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.


South Korea is a prominent destination for clinical trials in the Asia Pacific, with its superior medical infrastructure, highly educated medical personnel, and wide patient pool. In addition, increasing government support has led to an increase in the number of opportunities for drug development companies.

For instance, in April 2020, the Ministry of Food and Drug Safety announced a 5-year plan for the advancement of clinical trials in South Korea. This plan was launched to enhance clinical trial management by 2023.

The plan included three strategies, which involved improving international competitiveness in clinical trials, developing a clinical trial safety management system, and expanding treatment opportunities & communication systems for patients.

Reasons to subscribe to South Korea clinical trial patient recruitment services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea clinical trial patient recruitment services market databook

  • Our clientele includes a mix of clinical trial patient recruitment services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into South Korea clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea clinical trial patient recruitment services market size, by phase, 2018-2030 (US$M)

South Korea Clinical Trial Patient Recruitment Services Market Outlook Share, 2023 & 2030 (US$M)

South Korea clinical trial patient recruitment services market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more